354 related articles for article (PubMed ID: 2436840)
1. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
2. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxic cell activity linked to time of recurrence of herpes labialis.
Rola-Pleszczynski M; Lieu H
Clin Exp Immunol; 1984 Jan; 55(1):224-8. PubMed ID: 6319058
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
6. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
7. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
8. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis.
Rola-Pleszczynski M
J Clin Lab Immunol; 1981 Jul; 6(1):39-43. PubMed ID: 7265173
[TBL] [Abstract][Full Text] [Related]
10. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.
Cunningham AL; Merigan TC
J Immunol; 1984 Jan; 132(1):197-202. PubMed ID: 6418797
[TBL] [Abstract][Full Text] [Related]
11. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
[TBL] [Abstract][Full Text] [Related]
12. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
Sheridan JF; Aurelian L
Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
[TBL] [Abstract][Full Text] [Related]
13. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
14. Immunological responses of patients with recurrent herpes genitalis.
Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus-1-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononuclear cells.
Maccario R; Revello MG; Comoli P; Gerna G
Viral Immunol; 1992; 5(2):93-103. PubMed ID: 1319712
[TBL] [Abstract][Full Text] [Related]
16. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
17. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites.
Hendricks RL; Sugar J
Curr Eye Res; 1984 Mar; 3(3):473-80. PubMed ID: 6321105
[TBL] [Abstract][Full Text] [Related]
18. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
[TBL] [Abstract][Full Text] [Related]
19. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
20. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.
Wainberg MA; Portnoy JD; Clecner B; Hubschman S; Lagacé-Simard J; Rabinovitch N; Remer Z; Mendelson J
J Infect Dis; 1985 Sep; 152(3):441-8. PubMed ID: 2993440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
